Development of Broadband Low-Distortion 150-W Millimeter-Wave Helix TWT for Satellite Communications
IEEE Transactions on Plasma Science · 2026-06 · 54 (6) · 2943-2949
DOI: 10.1109/tps.2026.3691471 ↗Kurz gefasst
Fachartikel in der Zeitschrift IEEE Transactions on Plasma Science, 2026-06. Verfasst von Jun He und 6 weiteren Autor:innen. Die Arbeit nennt 15 Literaturangaben.
Abstract (Originalsprache)
To address the increasing bandwidth demands of high-throughput satellite (HTS) communications, a high-power, low-distortion Ka-band helix traveling-wave tube (TWT) has been developed for downlink applications. The TWT achieves 168-W continuous-wave (CW) output power with 57.1% minimum efficiency across 25–27.5 GHz. It exhibits excellent signal integrity with 0.22-nspp group delay, 0.43-dBpp gain fluctuation, 37.2°–47.5° phase shift, and 2.61°–3.33°/dB AM/PM conversion at saturation. Reliability is confirmed through a 720-h burn-in test, showing minimal variations: ±0.12 dB (output power), ±0.13 dB (gain), −0.28 mA (cathode current), and +0.06 mA (body current). This TWT provides a high-power, stable solution for advanced satellite communications.
Zitieren
APA
He, J., Li, H., Sun, Y., Duan, K., Liu, Q., Cao, L., & Zhai, D. (2026). Development of Broadband Low-Distortion 150-W Millimeter-Wave Helix TWT for Satellite Communications. IEEE Transactions on Plasma Science, 54(6), 2943-2949. https://doi.org/10.1109/tps.2026.3691471
Vancouver
He J, Li H, Sun Y, Duan K, Liu Q, Cao L, et al. Development of Broadband Low-Distortion 150-W Millimeter-Wave Helix TWT for Satellite Communications. IEEE Transactions on Plasma Science. 2026;54(6):2943-2949. doi:10.1109/tps.2026.3691471
BibTeX
@article{He2026,
author = {He, Jun and Li, Haiqiang and Sun, Yuhui and Duan, Kunqing and Liu, Qinglun and Cao, Linlin and Zhai, Dehui},
title = {Development of Broadband Low-Distortion 150-W Millimeter-Wave Helix TWT for Satellite Communications},
journal = {IEEE Transactions on Plasma Science},
year = {2026},
volume = {54},
number = {6},
pages = {2943--2949},
doi = {10.1109/tps.2026.3691471}
}
EUVIMED